STK39 and Hydrocephalus: Interestingly, both genetic knockout and intrathecal pharmacological knockout of either TLR4 or SPAK was found to attenuate the CSF hypersecretion and therefore treat the hydrocephalus, providing a strong preclinical mechanistic link, at least in mice [95].